Clinical Trials Logo

Clinical Trial Summary

The main purpose of this study is to measure the amyloid burden, defined as extracellular volume (ECV) assessed by Magnetic Resonance Imaging (MRI) over time in a subset of up to 150 participants enrolled in ION-682884-CS2 (NCT04136171).


Clinical Trial Description

This pilot study will determine the efficacy of ION-682284 in reducing the amyloid deposit on the heart tissue compared to placebo. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06073574
Study type Observational
Source Ionis Pharmaceuticals, Inc.
Contact
Status Active, not recruiting
Phase
Start date March 31, 2021
Completion date April 2026